$496 Million is the total value of Integral Health Asset Management, LLC's 71 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SYK | New | STRYKER CORPORATION | $14,273,500 | – | 50,000 | +100.0% | 2.88% | – |
| PKI | New | PERKINELMER INC | $11,327,100 | – | 85,000 | +100.0% | 2.28% | – |
| BIIB | New | BIOGEN INC | $11,121,200 | – | 40,000 | +100.0% | 2.24% | – |
| New | SAREPTA THERAPEUTICS INCput | $10,337,250 | – | 75,000 | +100.0% | 2.08% | – | |
| IDXX | New | IDEXX LABS INC | $10,001,600 | – | 20,000 | +100.0% | 2.02% | – |
| HUM | New | HUMANA INC | $9,709,200 | – | 20,000 | +100.0% | 1.96% | – |
| BAX | New | BAXTER INTL INC | $8,112,000 | – | 200,000 | +100.0% | 1.63% | – |
| BSX | New | BOSTON SCIENTIFIC CORP | $7,604,560 | – | 152,000 | +100.0% | 1.53% | – |
| RVMD | New | REVOLUTION MEDICINES INC | $7,472,700 | – | 345,000 | +100.0% | 1.50% | – |
| ALGN | New | ALIGN TECHNOLOGY INC | $7,351,080 | – | 22,000 | +100.0% | 1.48% | – |
| NARI | New | INARI MED INC | $6,174,000 | – | 100,000 | +100.0% | 1.24% | – |
| HOLX | New | HOLOGIC INC | $6,052,500 | – | 75,000 | +100.0% | 1.22% | – |
| LFST | New | LIFESTANCE HEALTH GROUP INC | $5,267,870 | – | 709,000 | +100.0% | 1.06% | – |
| ALKS | New | ALKERMES PLC | $5,046,010 | – | 179,000 | +100.0% | 1.02% | – |
| AGIO | New | AGIOS PHARMACEUTICALS INC | $4,892,610 | – | 213,000 | +100.0% | 0.99% | – |
| LH | New | LABORATORY CORP AMER HLDGS | $4,588,400 | – | 20,000 | +100.0% | 0.92% | – |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $4,523,000 | – | 100,000 | +100.0% | 0.91% | – |
| ACHC | New | ACADIA HEALTHCARE COMPANY IN | $4,407,250 | – | 61,000 | +100.0% | 0.89% | – |
| SGRY | New | SURGERY PARTNERS INC | $4,205,340 | – | 122,000 | +100.0% | 0.85% | – |
| CTLT | New | CATALENT INC | $3,285,500 | – | 50,000 | +100.0% | 0.66% | – |
| OPCH | New | OPTION CARE HEALTH INC | $3,208,770 | – | 101,000 | +100.0% | 0.65% | – |
| REGN | New | REGENERON PHARMACEUTICALS | $2,465,010 | – | 3,000 | +100.0% | 0.50% | – |
| New | ACLARIS THERAPEUTICS INCcall | $2,022,500 | – | 250,000 | +100.0% | 0.41% | – | |
| ALLO | New | ALLOGENE THERAPEUTICS INC | $2,000,700 | – | 405,000 | +100.0% | 0.40% | – |
| SKIN | New | THE BEAUTY HEALTH COMPANY | $1,919,760 | – | 152,000 | +100.0% | 0.39% | – |
| New | MERUS N Vcall | $1,840,000 | – | 100,000 | +100.0% | 0.37% | – | |
| GDRX | New | GOODRX HLDGS INC | $1,268,750 | – | 203,000 | +100.0% | 0.26% | – |
| TERN | New | TERNS PHARMACEUTICALS INC | $1,184,000 | – | 100,000 | +100.0% | 0.24% | – |
| New | NUVALENT INCput | $913,150 | – | 35,000 | +100.0% | 0.18% | – | |
| New | EXSCIENTIA PLCads | $805,600 | – | 152,000 | +100.0% | 0.16% | – | |
| DYN | New | DYNE THERAPEUTICS INC | $656,640 | – | 57,000 | +100.0% | 0.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-09
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 15 | Q3 2023 | 4.7% |
| SAGE THERAPEUTICS INC | 15 | Q2 2023 | 5.0% |
| BIOMARIN PHARMACEUTICAL INC | 15 | Q2 2023 | 4.1% |
| ENVISTA HOLDINGS CORPORATION | 14 | Q3 2023 | 4.0% |
| AKERO THERAPEUTICS INC | 14 | Q3 2023 | 1.5% |
| REVVITY INC | 13 | Q3 2023 | 4.2% |
| BLUEPRINT MEDICINES CORP | 13 | Q3 2023 | 3.3% |
| PTC THERAPEUTICS INC | 13 | Q2 2023 | 1.7% |
| ELEVANCE HEALTH INC | 12 | Q3 2023 | 6.7% |
| NEVRO CORP | 12 | Q4 2022 | 4.5% |
View Integral Health Asset Management, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-09 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-03 |
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-02 |
| 13F-HR | 2021-11-12 |
View Integral Health Asset Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.